Work

Suberoylanilide hydroxamic acid (Zolinza/vorinostat) sensitizes TRAIL-resistant breast cancer cells orthotopically implanted in BALB/c nude mice

Year: 2009

Type: article

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1535-7163.mct-08-1004

Authors: Sharmila Shankar, Rachel Davis, Karan P. Singh, Razelle Kurzrock, Douglas D. Ross, Rakesh K. Srivastava

Institutions: The University of Texas MD Anderson Cancer Center, University of North Texas Health Science Center, The University of Texas Health Science Center at Tyler

Language: English

Topic: Histone Deacetylase Inhibitors Research

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2120084347

FWCI: 3.083

Cites: 59

Cited by: 59

Related to: 10